Amedeo Smart

Free Medical Literature Service

 

Amedeo

Venous Thrombosis
  Free Subscription

Articles published in
Thromb Res
    October 2025
  1. LI S, Wang M, Xu Y
    Predictors of pulmonary infarction in pediatric pulmonary embolism: A retrospective cohort study.
    Thromb Res. 2025;255:109502.
    >> Share

  2. AVIEL G, Raccah-Hirsh B, Abu-Ghannam R, Oren N, et al
    Has systemic thrombolysis run its course? A systematic review and network meta-analysis of patients with intermediate- and high-risk pulmonary embolism.
    Thromb Res. 2025;255:109503.
    >> Share

    September 2025
  3. KELLER K, Schmitt VH, Sivanathan V, Hahad O, et al
    Cystic fibrosis and its impact on prognosis in pulmonary embolism.
    Thromb Res. 2025;255:109499.
    >> Share

  4. PEREZ MARTIN A, Leger L, Chea M, Boudemaghe T, et al
    Seasonality and territorial gradient of pulmonary embolism in France: an 8-year retrospective nationwide analysis.
    Thromb Res. 2025;255:109492.
    >> Share

  5. SORELLA S, Biglietto M, Zhdanovskaya N, Merli M, et al
    Full vs. low-dose of direct oral anticoagulants as extended secondary prophylaxis of venous thromboembolism in the splanchnic venous thrombosis.
    Thromb Res. 2025;255:109481.
    >> Share

  6. FAHEEM MSB, Fatima Y, Munir SU, Khabir M, et al
    Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999-2024: A population-based analysis using CDC WONDER Data.
    Thromb Res. 2025;255:109482.
    >> Share

  7. CHAN A, Chrysafi P, Angelini D, Schaefer JK, et al
    An international survey of clinician recommendations for physical activity after venous thromboembolism.
    Thromb Res. 2025;255:109478.
    >> Share

  8. IBRAHIM A, Shalabi L, Zreigh S, Tawfik AM, et al
    Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data.
    Thromb Res. 2025;254:109476.
    >> Share

    August 2025
  9. KADAKIA KT, Bikdeli B
    When clots go to court: Clinical insights from litigation for venous thromboembolism in orthopedic surgery.
    Thromb Res. 2025;254:109442.
    >> Share

  10. ARIF HA, Miner A, Moore ST, LeBrun G, et al
    Characteristics and outcomes of venous thromboembolism-related litigation in orthopaedic surgery.
    Thromb Res. 2025;254:109443.
    >> Share

  11. STENGER WJE, den Uil CA, Rietdijk WJR, Al Amri I, et al
    Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.
    Thromb Res. 2025;255:109420.
    >> Share

    July 2025
  12. BOCCATONDA A, Simion C, Brighenti A, Serra C, et al
    Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6 months of therapy: A narrative review.
    Thromb Res. 2025;253:109403.
    >> Share

  13. GONZALEZ-MENDOZA DE, Fernandez-Nogueira F, Uribe M, Chavez-Tapia NC, et al
    Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE).
    Thromb Res. 2025;253:109395.
    >> Share

  14. WHITWORTH H, Wagner K, Zelinski A, DiCocco E, et al
    A novel Computable phENotype To Identify Pulmonary Embolism in chilDrEn: The CENTIPEDE Study.
    Thromb Res. 2025;253:109385.
    >> Share

    June 2025
  15. JORGENSEN CT, Tavoly M, Pettersen HH, Fronaes S, et al
    Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry.
    Thromb Res. 2025;252:109386.
    >> Share

  16. FREUND O, Pelcman D, Urtreger NO, Bar-Shai A, et al
    High rate of immediate and early post-traumatic venous thromboembolism in combat soldiers.
    Thromb Res. 2025;252:109382.
    >> Share

  17. SOUZA MEM, Ferreira LGR, Silva NRO, Lopes LR, et al
    Thrombin generation assay in venous thromboembolism: A scoping review.
    Thromb Res. 2025;252:109384.
    >> Share

  18. MENDOZA-ZAMBRANO E, Ballaz-Quincoces A, Lobo JL, Gomez-Cuervo C, et al
    Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts.
    Thromb Res. 2025;252:109379.
    >> Share

  19. ZUIN M, Piazza G, Rigatelli G, Bongarzoni A, et al
    Clinical phenotypes and risk of early hemodynamic deterioration in intermediate-high-risk patients with acute pulmonary embolism.
    Thromb Res. 2025;252:109380.
    >> Share

  20. BORIS D, Tamara S, Jovan M, Sandra P, et al
    Comparing fibrinolytic strategies in intermediate-high-risk pulmonary embolism: Insights from a multicenter registry.
    Thromb Res. 2025;252:109372.
    >> Share

  21. RUEDA-CAMINO JA, Angelina-Garcia M, Trujillo-Luque D, Joya-Seijo MD, et al
    Sex-based differences in access to reperfusion therapies for pulmonary embolism in Spain during the 2016-2022 period.
    Thromb Res. 2025;252:109371.
    >> Share

  22. HAUKELAND-PARKER S, Jervan O, Ghanima W, Spruit MA, et al
    The effect of exercise-based rehabilitation on objective physical activity levels in patients with persistent dyspnoea following pulmonary embolism.
    Thromb Res. 2025;252:109362.
    >> Share

    May 2025
  23. BOUZID D, Rouzaud D, Rio J, Borie R, et al
    Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism.
    Thromb Res. 2025;252:109359.
    >> Share

  24. TEO TW, Tan SML, Chiang YY, Oh JR, et al
    Impact of mechanical pulmonary thrombectomy for intermediate-risk pulmonary embolism: Results from a prospective multicenter, multi-ethnic Asian registry.
    Thromb Res. 2025;251:109357.
    >> Share

  25. GONG A, Wei X, Liu Y, Chen Z, et al
    Corrigendum to "SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons" [Thromb. Res. volume 250 (2025) 109334].
    Thromb Res. 2025;251:109350.
    >> Share

  26. LEINWEBER ME, Taher F, Assadian A, Hofmann A, et al
    Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023.
    Thromb Res. 2025;251:109337.
    >> Share

  27. GONG A, Wei X, Liu Y, Chen Z, et al
    SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons.
    Thromb Res. 2025;250:109334.
    >> Share

  28. GROAT D, Martin KA, Rosovsky RP, Sanfilippo KM, et al
    Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment.
    Thromb Res. 2025;250:109338.
    >> Share

    April 2025
  29. BROWN C, Mallick R, Pecarskie A, Shaw JR, et al
    Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapy.
    Thromb Res. 2025;250:109335.
    >> Share

  30. ZHANG RS, Yuriditsky E, Truong HP, Zhang P, et al
    Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio.
    Thromb Res. 2025;250:109323.
    >> Share

    March 2025
  31. SQUIZZATO A, De Pascali F, Pengo V, Donadini MP, et al
    Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis.
    Thromb Res. 2025 Mar 29:109313. doi: 10.1016/j.thromres.2025.109313.
    >> Share

  32. KUMAR S, Razaqi N, Mehta R, Sah R, et al
    Comment on: "Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis".
    Thromb Res. 2025;249:109312.
    >> Share

  33. KUNO T, Koitabashi N, Yamashita Y, Morimoto T, et al
    Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2.
    Thromb Res. 2025;249:109311.
    >> Share

  34. ZHANG H, Lu X, Guo Z, Jiang X, et al
    Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism.
    Thromb Res. 2025;249:109310.
    >> Share

  35. AMIRSARDARI Z, Khalili A, Sharafi M, Mehrizi R, et al
    Metabolomics profiling in venous thromboembolism and its chronic sequelae - A systematic review.
    Thromb Res. 2025;249:109309.
    >> Share

  36. LIU K, Hu C, Zhou LY, Tang ZY, et al
    The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials.
    Thromb Res. 2025;249:109294.
    >> Share

    February 2025
  37. GIERTZ M, Aarnivala H, Michelsen SW, Bjorklund C, et al
    Venous thromboembolism in children with Hodgkin lymphoma - A population-based study in Sweden, Finland, and Denmark.
    Thromb Res. 2025;248:109287.
    >> Share

  38. WANG TF, Luo S, Gage BF, Schoen MW, et al
    Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism.
    Thromb Res. 2025;248:109284.
    >> Share

  39. VOSTATEK R, Trappl M, Englisch C, Hohensinner P, et al
    Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer.
    Thromb Res. 2025;248:109285.
    >> Share

    January 2025
  40. GHORBANZADEH A, Levin DL, Kuzo RS, McBane RD 2nd, et al
    Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli.
    Thromb Res. 2025;247:109275.
    >> Share

  41. SAAD M, Batool RM, Waqas SA, Sohail MU, et al
    Unveiling the trends: Growing cancer and venous thromboembolism mortality in older adults in the United States, 1999-2020.
    Thromb Res. 2025;247:109259.
    >> Share

  42. SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
    Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism.
    Thromb Res. 2025;247:109274.
    >> Share

  43. RASHEDI S, Bejjani A, Hunsaker AR, Aghayev A, et al
    Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports.
    Thromb Res. 2025;247:109271.
    >> Share

  44. HASSAN E, Sutton D, Buka RJ, Lowe G, et al
    Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies.
    Thromb Res. 2025;247:109258.
    >> Share

  45. CHARLES S, Fatrara T, Bouriche T, Bonifay A, et al
    Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis.
    Thromb Res. 2025;247:109256.
    >> Share

    December 2024
  46. LIN J, Li W, Zhang X, Zhou K, et al
    Thromboembolic events associated with immune checkpoint inhibitors in cancer patients: A Bayesian network meta-analysis.
    Thromb Res. 2024;246:109243.
    >> Share

  47. BOSCH FTM, Dijk F, Briede S, Groen JV, et al
    Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma.
    Thromb Res. 2024;246:109240.
    >> Share

  48. LI Y, Xi L, Wang D, Fan G, et al
    Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study.
    Thromb Res. 2024;246:109237.
    >> Share

  49. KENNY C, Lennon O, Klok FA, Matthews J, et al
    Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis.
    Thromb Res. 2024;246:109242.
    >> Share

  50. YANG D, Deng J, Huang S, He H, et al
    Clinical features, outcomes, and anticoagulant strategies in lung cancer-associated isolated distal deep vein thrombosis.
    Thromb Res. 2024;244:109193.
    >> Share

    November 2024
  51. TANDON P, Thompson C, Li K, McLeod SL, et al
    Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism.
    Thromb Res. 2024;245:109234.
    >> Share

  52. DE PASCALI F, Filippova YA, Donadini MP, Pengo V, et al
    Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis.
    Thromb Res. 2024;245:109225.
    >> Share

  53. GARCIA-GARCIA V, Barca-Hernando M, Lopez-Ruz S, Rosa-Linares C, et al
    Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study.
    Thromb Res. 2024;245:109228.
    >> Share

  54. PRANDONI P, Bilora F, Pesavento R, Pedrajas JM, et al
    DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2024;245:109226.
    >> Share

  55. VANDENHAZEL HL, Wilson AS, Ye X, Vazquez SR, et al
    Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah Health.
    Thromb Res. 2024;245:109216.
    >> Share

  56. AMSTER R, Watad A, Shani U, McGonagle D, et al
    Increased risk of pulmonary embolism in patients with dermatomyositis/polymyositis, a retrospective cohort study from Israel.
    Thromb Res. 2024;244:109203.
    >> Share

    October 2024
  57. ZHENG X, Xu M, Zhang Z, Yang L, et al
    Microbial signatures in chronic thromboembolic pulmonary hypertension thrombi: Insights from metagenomic profiling of fresh and organized thrombi.
    Thromb Res. 2024;244:109204.
    >> Share

  58. UNO H, Xiong H, Cronin C, Schrag D, et al
    Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial.
    Thromb Res. 2024;244:109184.
    >> Share

  59. BRICENO W, Gonzalez S, Rodriguez C, Castillo A, et al
    Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study.
    Thromb Res. 2024;244:109179.
    >> Share

  60. YURIDITSKY E, Zhang RS, Zhang P, Horowitz JM, et al
    Inferior vena cava contrast reflux grade is associated with a reduced cardiac index in acute pulmonary embolism.
    Thromb Res. 2024;244:109177.
    >> Share

    September 2024
  61. MCELROY S, Cramer E, Amos L
    COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics.
    Thromb Res. 2024;243:109169.
    >> Share

  62. CHRISTODOULOU KC, Mohr K, Uphaus T, Jagersberg M, et al
    Evolving patterns of intracranial hemorrhage in advanced therapies in patients with acute pulmonary embolism.
    Thromb Res. 2024;243:109168.
    >> Share

  63. MAESTRE A, Martin Del Pozo M, Moustafa F, Chopard R, et al
    Predicting intracranial bleeding during anticoagulation for venous thromboembolism within different time frames: Findings from the RIETE registry.
    Thromb Res. 2024;243:109153.
    >> Share

  64. SYROWATKA A, Pullman A, Pajares E, White K, et al
    Accurately identifying incident cases of venous thromboembolism in the electronic health record: Performance of a novel phenotyping algorithm.
    Thromb Res. 2024;243:109143.
    >> Share

  65. TIAN H, Zhang Y, Liu J, Yang Y, et al
    Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES.
    Thromb Res. 2024;243:109146.
    >> Share

  66. FERREIRA BA, Danielian PLLB, Caetano GC, Ferreira CRL, et al
    Incidence of venous thromboembolism and adequacy of thromboprophylaxis in 2380 acutely-ill hospitalized patients: Results from the PROFMiG cohort study.
    Thromb Res. 2024;243:109145.
    >> Share

  67. SMIT JM, Haaksma ME, Heldeweg MLA, Adamse DS, et al
    Incidence of catheter-related thrombosis and its association with outcome in critically ill patients: A prospective observational study.
    Thromb Res. 2024;241:109068.
    >> Share

    August 2024
  68. BERGGREEN C, Schroder JH, Christensen T, Szejniuk WM, et al
    TO INFORM OR NOT TO INFORM about venous thromboembolisms - A qualitative study on communication between healthcare professionals and patients with lung cancer.
    Thromb Res. 2024;243:109132.
    >> Share

  69. HANSEN AL, Hojen AA, Lindegaard SF, Grove EL, et al
    The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.
    Thromb Res. 2024;242:109133.
    >> Share

  70. REYES GIL M, Pantanowitz J, Rashidi HH
    Venous thromboembolism in the era of machine learning and artificial intelligence in medicine.
    Thromb Res. 2024;242:109121.
    >> Share

  71. CHIANG CH, Xu X, Song J, Xanthavanij N, et al
    The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer.
    Thromb Res. 2024;242:109119.
    >> Share

  72. DU Y, Yang A, Wang X
    Accuracy of transthoracic lung ultrasound for diagnosing pulmonary embolism: An updated systematic review and meta-analysis.
    Thromb Res. 2024;241:109112.
    >> Share

    July 2024
  73. ZHU YF, Ma JH, Qian H, Shen NN, et al
    Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting.
    Thromb Res. 2024;241:109107.
    >> Share

  74. CHRISTENSEN MA, Stubblefield WB, Wang G, Altheimer A, et al
    Derivation and external validation of a portable method to identify patients with pulmonary embolism from radiology reports: The READ-PE algorithm.
    Thromb Res. 2024;241:109105.
    >> Share

  75. BEG KA, Chen S, Makoni M, Khan O, et al
    Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients.
    Thromb Res. 2024;241:109098.
    >> Share

  76. SRIVASTAVA S, Kumari B, Garg I, Prince, et al
    Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE).
    Thromb Res. 2024;241:109104.
    >> Share

  77. VICTORRI-VIGNEAU C, Guerlais M, Jaulin E, Laforgue EJ, et al
    Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert.
    Thromb Res. 2024;241:109096.
    >> Share

  78. PEREZ-JACOISTE ASIN MA, Blanco Molina A, Gomez-Cuervo C, Diaz-Pedroche MDC, et al
    Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry.
    Thromb Res. 2024;241:109087.
    >> Share

  79. LIPPI G, Mattiuzzi C
    Analysis of real-world data pulmonary embolism as the underlying cause of death during the COVID-19 pandemic.
    Thromb Res. 2024;241:109089.
    >> Share

    June 2024
  80. OVERVAD TF, Severinsen MT, Johnsen SP, Madsen SS, et al
    Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register.
    Thromb Res. 2024;241:109074.
    >> Share

  81. KAPTEIN FHJ, Stoger JL, van Dam LF, Ninaber MK, et al
    Computed tomography diagnosis of pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2024;241:109071.
    >> Share

  82. MA SG, Yang Y, Huang Y
    Venous thromboembolism risk assessment scale for prediction of venous thromboembolism in inpatients with cancer: A meta-analysis.
    Thromb Res. 2024;240:109058.
    >> Share

    May 2024
  83. EMAD Y, Ragab Y, Farber HW, Erkan D, et al
    Pulmonary embolism versus pulmonary vasculitis in Hughes-Stovin syndrome: Characteristic computed tomography pulmonary angiographic findings and diagnostic and therapeutic implications. HSS International Study Group.
    Thromb Res. 2024;239:109040.
    >> Share

  84. GIRARDI L, Ciuffini LA, Mai V, Santagata D, et al
    Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism.
    Thromb Res. 2024;239:109037.
    >> Share

  85. IOURINETS J, Sawalski C, Desai P, Sutherland D, et al
    Prevalence and outcome of acute pulmonary embolism in hospitalized patients with a history of inflammatory bowel disease.
    Thromb Res. 2024;239:109035.
    >> Share

  86. WAN T, Garland SJ, Drury CT, Lambert J, et al
    Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients.
    Thromb Res. 2024;239:109036.
    >> Share

  87. CENAT JM, Dromer E, Farahi SMMM, Ndamage CM, et al
    Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis.
    Thromb Res. 2024;238:197-205.
    >> Share

  88. MITTA P, DiFatta J, Mahler C, Huang J, et al
    Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies.
    Thromb Res. 2024;239:109027.
    >> Share

    April 2024
  89. JOHARIVARNOOSFADERANI N, Abedi SS
    A thromboembolic event as the first presentation of essential thrombocytosis: A case report.
    Thromb Res. 2024;238:103-104.
    >> Share

  90. DOGAN C, Samanci S
    The course of pulmonary embolism in individuals recovered from COVID-19.
    Thromb Res. 2024;238:232-234.
    >> Share

  91. DE JONG CMM, Kroft LJM, van Mens TE, Huisman MV, et al
    Modern imaging of acute pulmonary embolism.
    Thromb Res. 2024;238:105-116.
    >> Share

  92. IKEDA S, Yamashita Y, Morimoto T, Chatani R, et al
    Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
    Thromb Res. 2024;238:27-36.
    >> Share

  93. PALARETI G, Legnani C, Tosetto A, Poli D, et al
    D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
    Thromb Res. 2024;238:52-59.
    >> Share

  94. MO M, Lian Z, Xiang Y, Du X, et al
    Association between perioperative red blood cell transfusions and postoperative venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2024;237:163-170.
    >> Share

  95. LOPEZ N, Zamora-Martinez C, Montoya-Rodes M, Gabara C, et al
    Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital.
    Thromb Res. 2024;236:136-143.
    >> Share

    March 2024
  96. MOKART D, Serre E, Bruneel F, Kouatchet A, et al
    Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study.
    Thromb Res. 2024;237:129-137.
    >> Share

  97. GUTIERREZ-GUISADO J, Calvo-Sotelo AE, Hernandez-Blasco L, Fidalgo A, et al
    Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.
    Thromb Res. 2024;237:94-99.
    >> Share

  98. BAASTRUP NN, Buch AK, Gundestrup AK, Olsen ASF, et al
    The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery programme.
    Thromb Res. 2024;237:46-51.
    >> Share

  99. LUTFI A, O'Rourke E, Crowley M, Craig E, et al
    VTE risk assessment, prevention and diagnosis in pregnancy.
    Thromb Res. 2024;235:164-174.
    >> Share

    February 2024
  100. OGIHARA Y, Yamashita Y, Morimoto T, Chatani R, et al
    Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
    Thromb Res. 2024;236:191-200.
    >> Share

  101. FLYNN C, Baldassarra J, Hamidi A
    Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study.
    Thromb Res. 2024;236:127-129.
    >> Share

  102. RAJPURKAR M, Rosovsky RP, Williams S, Chan AKC, et al
    Considerations for instituting pediatric pulmonary embolism response teams: A tool kit.
    Thromb Res. 2024;236:97-107.
    >> Share

  103. BHANGU G, Murray A, Qayyum A, Goumeniouk N, et al
    Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review.
    Thromb Res. 2024;236:108-116.
    >> Share

  104. SIMARD C, Poirier-Blanchette L, Rizzolo A, Cafaro T, et al
    Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative.
    Thromb Res. 2024;236:68-73.
    >> Share

  105. BAO L, Fang LJ, Xiao MY, Lu MQ, et al
    Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study.
    Thromb Res. 2024;236:130-135.
    >> Share

  106. VAN OMMEN CH, Luijnenburg SE
    Anticoagulation of pediatric patients with venous thromboembolism in 2023.
    Thromb Res. 2024 Feb 10:S0049-3848(24)00032.
    >> Share

    January 2024
  107. FAN Z, Xu S, Deng Y, Wei L, et al
    Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism.
    Thromb Res. 2024;235:68-74.
    >> Share

  108. CHAIBI S, Roy PM, Guenegou AA, Tran Y, et al
    Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial.
    Thromb Res. 2024;235:79-87.
    >> Share

  109. YOO J, Jeon J, Baik M, Kim J, et al
    Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study.
    Thromb Res. 2024;235:32-40.
    >> Share

  110. CHOPARD R, Bertoletti L, Piazza G, Jimenez D, et al
    External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry.
    Thromb Res. 2024;235:22-31.
    >> Share

  111. ABDULREHMAN J, Harrigan A, Simard C, Tagalakis V, et al
    TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.
    Thromb Res. 2024;235:11-14.
    >> Share

  112. ABRAHAO R, Brunson A, Chubak J, Wernli KJ, et al
    Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
    Thromb Res. 2024;235:1-7.
    >> Share

  113. CASPERSEN CK, Ingemann-Molden S, Grove EL, Hojen AA, et al
    Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review.
    Thromb Res. 2024;235:52-67.
    >> Share

  114. TIRATRAKOONSEREE T, Charoenpichitnun S, Natesirinilkul R, Songthawee N, et al
    Clinical prediction tool to identify children at risk of pulmonary embolism.
    Thromb Res. 2024;234:151-157.
    >> Share

  115. HOUGHTON DE, Casanegra AI, Wysokinski WE, Padrnos LJ, et al
    COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds.
    Thromb Res. 2024;235:8-10.
    >> Share

  116. YAN AR, Samarawickrema I, Naunton M, Peterson GM, et al
    Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Thromb Res. 2024;234:120-133.
    >> Share

  117. CHATANI R, Yamashita Y, Morimoto T, Mushiake K, et al
    Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
    Thromb Res. 2024;234:86-93.
    >> Share

    December 2023
  118. OBRADOVIC S, Dzudovic B, Simpson T, Matijasevic J, et al
    S wave resolution in lead aVL at 48 hours after pulmonary embolism admission predicts lower mortality.
    Thromb Res. 2023;234:36-38.
    >> Share

  119. GUMAN NAM, Kaptein FHJ, Lohle SB, Mairuhu ATA, et al
    Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: A multicenter retrospective cohort study.
    Thromb Res. 2023;233:181-188.
    >> Share

  120. PUCHADES R, Tung-Chen Y, Salgueiro G, Lorenzo A, et al
    Artificial intelligence for predicting pulmonary embolism: A review of machine learning approaches and performance evaluation.
    Thromb Res. 2023;234:9-11.
    >> Share

  121. RUEDA-CAMINO JA, Barba R, Otalora S, Bura-Riviere A, et al
    Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism.
    Thromb Res. 2023;233:165-172.
    >> Share

  122. FRENZEL L, Decaux O, Macro M, Belhadj-Merzoug K, et al
    Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
    Thromb Res. 2023;233:153-164.
    >> Share

  123. TRITSCHLER T, Sadeghipour P, Bikdeli B
    Subgroup analysis in randomized controlled trials: Useful or misleading?
    Thromb Res. 2023;232:160-162.
    >> Share

    November 2023
  124. LIPPI G, Mattiuzzi C, Favaloro EJ
    Recent monthly mortality for pulmonary embolism in the US.
    Thromb Res. 2023;233:99-100.
    >> Share

  125. INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
    Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
    Thromb Res. 2023;233:69-81.
    >> Share

  126. NAJARRO M, Briceno W, Rodriguez C, Muriel A, et al
    Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2023;233:18-24.
    >> Share

  127. APARICIO I, Iranzo P, Reyes R, Bote H, et al
    Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
    Thromb Res. 2023;232:133-137.
    >> Share

  128. CHEN AC, Rao AS, Oropallo A, Goldhaber SZ, et al
    Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
    Thromb Res. 2023;232:123-132.
    >> Share

  129. HEERINK JS, Oudega R, Gemen E, Hopstaken R, et al
    Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism.
    Thromb Res. 2023;232:113-122.
    >> Share

  130. ZABCZYK M, Kruk A, Natorska J, Undas A, et al
    Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
    Thromb Res. 2023;232:70-76.
    >> Share

  131. BIKDELI B, Piazza G
    The CORONA-VTE network registry: Revisiting the realities while encouraging enthusiasm.
    Thromb Res. 2023;231:7.
    >> Share

    October 2023
  132. PAREDES D, Del Carmen Diaz-Pedroche M, Gomez-Cuervo C, Perez-Jacoiste A, et al
    Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism.
    Thromb Res. 2023;232:54-61.
    >> Share

  133. KAPTEIJN MY, Lanting VR, Kaptein FHJ, Guman NAM, et al
    RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
    Thromb Res. 2023;232:27-34.
    >> Share

  134. TSUJISAKA Y, Yamashita Y, Morimoto T, Takase T, et al
    Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
    Thromb Res. 2023;232:35-42.
    >> Share

  135. ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
    Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Thromb Res. 2023;231:91-98.
    >> Share

  136. YHIM HY, Lee J, Kim KH, Kim SA, et al
    Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
    Thromb Res. 2023;231:50-57.
    >> Share

    September 2023
  137. MAVROMANOLI AC, Jimenez D, Sanchez O, Sobkowicz B, et al
    Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
    Thromb Res. 2023;231:29-31.
    >> Share

  138. RAMBAUD G, Mai V, Motreff C, Sanchez O, et al
    Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
    Thromb Res. 2023;231:58-64.
    >> Share

  139. XU Y, Khan F, Kovacs MJ, Sabri E, et al
    Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
    Thromb Res. 2023;231:32-38.
    >> Share

  140. DRAGSBAEK SJ, Lyhne MD, Hansen JV, Pedersen CCE, et al
    A porcine model of human-like chronic thromboembolic pulmonary disease.
    Thromb Res. 2023;231:25-28.
    >> Share

  141. STALS MAM, Beenen LFM, Coppens M, Faber LM, et al
    Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
    Thromb Res. 2023;231:65-75.
    >> Share

  142. AVERY J, Guffey D, Ma S, Basom R, et al
    Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Thromb Res. 2023;229:1-6.
    >> Share

    August 2023
  143. CHU G, Seelig J, Cannegieter SC, Gelderblom H, et al
    Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
    Thromb Res. 2023;230:98-104.
    >> Share

  144. SCOTT DM, Abud A, Amor M, Saemi A, et al
    Natural Language Processing tool accurately identifies acute venous thromboembolism.
    Thromb Res. 2023;229:252-254.
    >> Share

  145. FELIX G, Ferreira E, Ribeiro A, Guerreiro I, et al
    Predictors of cancer in patients with acute pulmonary embolism.
    Thromb Res. 2023;230:11-17.
    >> Share

    July 2023
  146. MEYER HJ, Gottschling S, Bar C, Wienke A, et al
    CT coronary calcium score is a prognostic marker in acute pulmonary embolism.
    Thromb Res. 2023;229:255-257.
    >> Share

  147. BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
    Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2023;229:139-145.
    >> Share

  148. ANIJS RJS, Chen Q, van der Hulle T, Versteeg HH, et al
    Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Thromb Res. 2023;229:90-98.
    >> Share

  149. ALMAJDI A, Almutairi S, Alharbi M
    Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis.
    Thromb Res. 2023;229:77-85.
    >> Share

  150. HYDER SN, Han HB, Ash S, Horne BD, et al
    Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
    Thromb Res. 2023;227:45-50.
    >> Share

    June 2023
  151. LOWE G, Wu O, van Hylckama Vlieg A, Folsom A, et al
    Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.
    Thromb Res. 2023;229:31-39.
    >> Share

  152. FILIPPI L, Turcato G, Milan M, Barbar S, et al
    Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.
    Thromb Res. 2023;229:73-76.
    >> Share

  153. JERVAN O, Dhayyat A, Gleditsch J, Haukeland-Parker S, et al
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism.
    Thromb Res. 2023;229:7-14.
    >> Share

  154. MUNOZ AJ, Souto JC, Lecumberri R, Obispo B, et al
    Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
    Thromb Res. 2023;228:181-188.
    >> Share

  155. JAOUEN S, Mingant F, Lippert E, Galinat H, et al
    Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
    Thromb Res. 2023;228:191-199.
    >> Share

  156. ZUIN M, Bikdeli B, Davies J, Krishnathasan D, et al
    Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019.
    Thromb Res. 2023;228:72-80.
    >> Share

  157. BROWN C, Brandt W, Wang TF, Delluc A, et al
    Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
    Thromb Res. 2023;228:81-84.
    >> Share

    May 2023
  158. OTERO R, Lobo JL, Lopez R, Fernandez C, et al
    Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
    Thromb Res. 2023;228:1-9.
    >> Share

  159. ADDA-REZIG I, Cossu J, Falvo N, Ecarnot F, et al
    Home treatment versus early discharge for the outpatient management of acute pulmonary embolism: A non-interventional, post-hoc cohort analysis.
    Thromb Res. 2023;227:25-33.
    >> Share

  160. PALLARES ROBLES A, Ten Cate V, Lenz M, Schulz A, et al
    Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification.
    Thromb Res. 2023 May 8:S0049-3848(23)00124.
    >> Share

    April 2023
  161. LI HY, Wang J, Wang T, Wang HS, et al
    Management of venous thromboembolism in pediatric patients: Quality assessment of clinical practice guidelines and variations in recommendations.
    Thromb Res. 2023;226:107-116.
    >> Share

  162. CHIU J, Lazo-Langner A
    Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review.
    Thromb Res. 2023;226:141-149.
    >> Share

  163. DROPPA M, Zdanyte M, Henes JK, Gawaz M, et al
    Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis.
    Thromb Res. 2023;226:33-35.
    >> Share

  164. KAPTEIN FHJ, Kroft LJM, van Dam LF, Stoger JL, et al
    Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes.
    Thromb Res. 2023;226:51-55.
    >> Share

  165. KELLER K, Kohring C, Farmakis IT, Valerio L, et al
    Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
    Thromb Res. 2023;226:9-17.
    >> Share

  166. QIAO N, Zhang Q, Chen L, He W, et al
    Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
    Thromb Res. 2023;226:1-8.
    >> Share

  167. COHEN A, Noxon V, Dhamane A, Bruette R, et al
    Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
    Thromb Res. 2023;226:117-126.
    >> Share

    March 2023
  168. ZBINDEN S, Voci D, Grigorean A, Holy EW, et al
    Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism.
    Thromb Res. 2023;225:73-78.
    >> Share

  169. MATUSOV Y, Yaqoob M, Karumanchi A, Lipshutz HG, et al
    Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
    Thromb Res. 2023;225:57-62.
    >> Share

  170. KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
    Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
    Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
    >> Share

  171. ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
    Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
    Thromb Res. 2023;225:28-32.
    >> Share

    February 2023
  172. WIKLUND P, Medson K, Elf J
    Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
    Thromb Res. 2023;224:65-72.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016